IDSA News - 01/01/2008  (Plain Text Version)

Return to Graphical Version

 

In this issue:
•  Adult and Adolescent HIV Treatment Guidelines Updated
•  IDSA Publishes Updated Guidelines on Aspergillus
•  CDC Releases Updated Immunization Schedule
•  Drug Approvals, Shortages, Recalls, Adverse Events
•  EIN Reports Problems with Vancomycin Levels
•  In the IDSA Journals
•  Outbreaks and Bioemergencies
•  Developing a Research Agenda for HIV and Aging
•  First Annual IDSA Fellows’ In-Training Exam June 3 and 4
•  New Resources for State and Regional Societies
•  CDC Finds Low Rates of Adult Immunization
•  IDSA Advocacy Update
•  New Law Requires Free Access to NIH-funded Research
•  Members on the Move
•  Welcome, New IDSA Members!
•  WHO Promotes Community Health Workers for HIV/AIDS Care

 

Adult and Adolescent HIV Treatment Guidelines Updated

The Department of Health and Human Services has released a new version of the “Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents.”  The update includes new information on:

  • lab tests to run for newly diagnosed patients during their initial clinic visit
  • updated recommendations on when to start treatment
  • management of treatment-experienced patients, including suggestions on prescribing the recently FDA-approved drugs, Maraviroc and Raltegravir

Changes to the guidelines are summarized at the beginning of the guidelines and are highlighted in yellow throughout the text and tables.

The updated guidelines are available on the NIH AIDS info Web site.